What reviewers say about Plus therapeutics
What does Plus therapeutics do?
Plus Therapeutics is a global, public company that develops and commercializes stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery, and other serious conditions. Their pipeline includes lead drug candidates RNL and DocePLUS, which are being developed in the U.S. by a team of scientists and physicians.
Are there any complaints about Plus therapeutics?
The reviews on file do not mention specific complaints, as even the lowest-rated reviews describe positive experiences with the products, delivery, and customer service.
What do people say about Plus therapeutics outside Trustburn?
Outside of Trustburn, discussions mention the company's website and its ReSPECT Clinical Trials page, with users sharing links to these resources and the company's Instagram account.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Tiếng Việt
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Plus therapeutics
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions.
Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
- Website
- plustherapeutics.com
- Phone
- 12109746900
- [email protected]
- Address
- 4200 marathon boulevard
- Categories
- Pharmaceuticals
